Tertiary cytoreduction for recurrent ovarian carcinoma: an updated and expanded analysis

OBJECTIVE: We sought to describe clinicopathologic and surgical factors associated with oncologic outcomes in patients undergoing tertiary cytoreduction and to present a clinical model to identify patients with high-grade serous ovarian cancer (HGSOC) who may benefit most from tertiary cytoreduction...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Gynecol Oncol
Main Authors: Manning-Geist, Beryl L, Chi, Dennis S, Roche, Kara Long, Zivanovic, Oliver, Sonoda, Yukio, Gardner, Ginger J, O’Cearbhaill, Roisin E, Abu-Rustum, Nadeem R, Leitao, Mario M
Formato: Artigo
Idioma:Inglês
Publicado: 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8319116/
https://ncbi.nlm.nih.gov/pubmed/34045053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2021.05.015
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares